The purpose of the company is the research, development, commercialization, and provision of technologies, products, and services in the fields of biotechnology, immunology, and artificial intelligence. This includes the design, testing, and optimization of biopharmaceutical active ingredients, platforms for immune risk prediction, as well as data-driven systems. The company can acquire, develop, manage, and license intellectual property; collaborate with academic, clinical, and industrial partners; offer scientific, technical, and advisory services; and carry out all activities that serve its purposes. The company can establish branches and subsidiaries in Switzerland and/or abroad and invest in other companies in Switzerland and/or abroad, acquire, hold, encumber, and dispose of real estate or intellectual property rights in Switzerland and/or abroad, and conduct all commercial, financial, or other transactions that are directly or indirectly related to the company's purpose. Furthermore, the company can grant loans or other financing to its direct or indirect shareholders and their direct or indirect subsidiaries, as well as to third parties, with or without charge, and provide securities of all kinds for the liabilities of such persons or group companies, including guarantees, pledges, and fiduciary transfers of the company's assets. In addition, it can engage in or participate in liquidity equalization/net liquidity centralization (cash pooling) with group companies, including periodic balance adjustments (balancing), without consideration, on preferential terms, interest-free, excluding the company's profit-making intent, and assuming clumping risks.
Outbound Leads by COHAGA